Our operating subsidiaries

Over the last decade, CGT Catapult has established the infrastructure and networks to work with industry in the development, production and adoption of ATMPs. In that time, we have sought to add additional value to the cell and gene therapy field by ensuring access to expertise across world class manufacturing technology and processes, regulatory affairs, health economics, NHS/market access, advanced skills and training, clinical operations and non-clinical safety.